Vidhi Pandya, Nidhi Trivedi, Bhupendra Prajapati, Amit Patel, Samir Patel, Alkesh Patel et al. Tofacitinib laden MCM-48 mesoporous silica nanogel for topical psoriasis: ex vivo and in vivo therapeutic validation. // European Journal of Pharmaceutics and Biopharmaceutics. – 2027. – DOI: 10.1016/j.ejpb.2026.115294. – URL: https://doi.org/10.1016/j.ejpb.2026.115294
Vidhi Pandya, Nidhi Trivedi, Bhupendra Prajapati, Amit Patel, Samir Patel, Alkesh Patel, Nehangi Patel, & Ravish J. Patel (2027). Tofacitinib laden MCM-48 mesoporous silica nanogel for topical psoriasis: ex vivo and in vivo therapeutic validation. European Journal of Pharmaceutics and Biopharmaceutics. https://doi.org/10.1016/j.ejpb.2026.115294
Vidhi Pandya, et al. “Tofacitinib laden MCM-48 mesoporous silica nanogel for topical psoriasis: ex vivo and in vivo therapeutic validation.” European Journal of Pharmaceutics and Biopharmaceutics, 2027. doi:10.1016/j.ejpb.2026.115294.
@article{Pandya2027,
title = {Tofacitinib laden MCM-48 mesoporous silica nanogel for topical psoriasis: ex vivo and in vivo therapeutic validation},
author = {Pandya, Vidhi and Trivedi, Nidhi and Prajapati, Bhupendra and Patel, Amit and Patel, Samir and Patel, Alkesh and Patel, Nehangi and Patel, Ravish J.},
journal = {European Journal of Pharmaceutics and Biopharmaceutics},
year = {2027},
doi = {10.1016/j.ejpb.2026.115294},
url = {https://doi.org/10.1016/j.ejpb.2026.115294}
}